Standout Papers

NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer 2024 202639
  1. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer (2024)
    Federico Nichetti, Chiara Pircher et al. JAMA Network Open

Immediate Impact

54 standout
Sub-graph 1 of 24

Citing Papers

Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
2 intermediate papers

Works of Federico Nichetti being referenced

Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives
2018
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study
2017

Author Peers

Author Last Decade Papers Cites
Federico Nichetti 332 155 152 161 47 553
Seyoung Seo 361 290 110 209 44 647
Han Jo Kim 261 146 128 244 47 632
Benjamin L. Schlechter 187 89 104 146 49 624
Dongmei Diao 228 152 229 275 36 630
Meral Günaldı 271 107 107 168 54 617
Faruk Taş 231 97 122 153 44 569
Olga Nigro 312 154 94 161 38 585
Gabriel Tinoco 220 175 93 136 50 548
Ran Hong 156 110 60 192 53 572
Meijin Huang 195 85 154 256 31 508

All Works

Loading papers...

Rankless by CCL
2026